| Improved physical stability of an Antibody Drug Conjugate using Host-Guest chemistry S Sonzini, ML Greco, T Cailleau, LR Adams, LA Masterson, ... Bioconjugate Chemistry, 2019 | | 2019 |
| TR1801‐ADC: A highly potent cMet antibody‐drug conjugate with high activity in patient‐derived xenograft models of solid tumors M Gymnopoulos, O Betancourt, V Blot, R Fujita, D Galvan, V Lieuw, ... Molecular oncology, 2019 | | 2019 |
| Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study CL Vinhaes, D Oliveira-de-Souza, PS Silveira-Mattos, B Nogueira, R Shi, ... Cytokine 123, 154759, 2019 | 1 | 2019 |
| Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development T Beites, K O’Brien, D Tiwari, CA Engelhart, S Walters, J Andrews, ... Nature communications 10 (1), 1-12, 2019 | | 2019 |
| C4-Phenylthio β-lactams: Effect of the chirality of the β-lactam ring on antimicrobial activity R Kuskovsky, D Lloyd, K Arora, BJ Plotkin, JM Green, HI Boshoff, ... Bioorganic & medicinal chemistry 27 (20), 115050, 2019 | | 2019 |
| Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosis Y Park, YM Ahn, S Jonnala, S Oh, JM Fisher, MB Goodwin, TR Ioerger, ... Antimicrobial agents and chemotherapy 63 (10), e01006-19, 2019 | | 2019 |
| Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding Mode AJ Whitehouse, MDJ Libardo, M Kasbekar, PD Brear, G Fischer, ... Journal of medicinal chemistry, 2019 | 1 | 2019 |
| Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline Z Wang, V Soni, G Marriner, T Kaneko, HIM Boshoff, CE Barry, KY Rhee Proceedings of the National Academy of Sciences 116 (39), 19646-19651, 2019 | | 2019 |
| The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis K Dheda, T Gumbo, G Maartens, KE Dooley, M Murray, J Furin, ... The Lancet Respiratory Medicine 7 (9), 820-826, 2019 | | 2019 |
| TR1801-ADC, an optimized anti cMet PBD ADC with high efficacy in solid tumors of the GI tract and head & neck cancer M Gymnopoulos, O Betancourt, V Blot, R Fujita, D Ly, S Nguyen, ... Cancer Research 79 (13 Supplement), 225-225, 2019 | | 2019 |
| Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggers SJ Gregson, AM Barrett, NV Patel, GD Kang, D Schiavone, E Sult, ... European Journal of Medicinal Chemistry, 2019 | 1 | 2019 |
| Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations D Oliveira-de-Souza, CL Vinhaes, MB Arriaga, NP Kumar, ... Scientific reports 9 (1), 8002, 2019 | 1 | 2019 |
| A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasis P MacGregor, AL Gonzalez-Munoz, F Jobe, MC Taylor, S Rust, ... PLoS neglected tropical diseases 13 (5), e0007373, 2019 | 1 | 2019 |
| Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa S Wasserman, G Louw, L Ramangoaela, G Barber, C Hayes, SV Omar, ... Journal of Antimicrobial Chemotherapy, 2019 | | 2019 |
| Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization N Strydom, SV Gupta, WS Fox, LE Via, H Bang, M Lee, S Eum, TS Shim, ... PLoS medicine 16 (4), e1002773, 2019 | 12 | 2019 |
| Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populations. DO Souza, CL Vinhaes, MB Arriaga, NP Kumar, JMC Angulo, R Shi, ... Nature Research, 2019 | | 2019 |
| A semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography … ST Malherbe, P Dupont, I Kant, P Ahlers, M Kriel, AG Loxton, RY Chen, ... EJNMMI research 8 (1), 55, 2018 | 1 | 2018 |
| Structures of DPAGT1 explain glycosylation disease mechanisms and advance TB antibiotic design YY Dong, H Wang, ACW Pike, SA Cochrane, S Hamedzadeh, ... Cell 175 (4), 1045-1058. e16, 2018 | 12 | 2018 |
| Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2 … S Oh, Y Park, CA Engelhart, JB Wallach, D Schnappinger, K Arora, ... Journal of medicinal chemistry 61 (22), 9952-9965, 2018 | 4 | 2018 |
| The present state of the tuberculosis drug development pipeline MDJ Libardo, HIM Boshoff, CE Barry III Current opinion in pharmacology 42, 81-94, 2018 | 13 | 2018 |
